Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.

Shin-Ichi UenoTaku HatanoAyami OkuzumiShinji SaikiYutaka OjiAkio MoriTakahiro KoinumaMotoki FujimakiHaruka Takeshige-AmanoAkihide KondoNaoyuki YoshikawaTakahiro NojiriMakoto KuranoKeiko YasukawaYutaka YatomiHitoshi IkedaNobutaka Hattori

Published in: Annals of clinical and translational neurology (2020)

%HNA was significantly increased in iPD and PARK2 patients compared with controls, regardless of disease course and severity. Oxidative stress might be increased from the early stages of iPD and PARK2 and play an important role in their pathomechanisms.

Keyphrases

oxidative stress
end stage renal disease
chronic kidney disease
ejection fraction
dna damage
newly diagnosed
ischemia reperfusion injury
peritoneal dialysis
induced apoptosis
prognostic factors
diabetic rats
patient reported
endoplasmic reticulum stress
heat shock protein